Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,738,536
+$1,993,731 QoQ
Shares Held
190,972
+139.0% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 158 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ZVRA ranks #109 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ZVRA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,738,536 190,972
2026-03-31 $744,805 79,915
2025-12-31 $1,622,914 181,129
2025-09-30 $1,448,475 152,311
2024-12-31 $97,810 11,728
2022-06-30 $478,740 107,341
2022-03-31 $1,056,803 210,100
2021-12-31 $526,362 60,432
2021-09-30 $940,557 100,810